Naftidrofuryl for acute stroke
Referencias
Additional references
Davis PTG, Steiner TJ. Naftidrofuryl fumarate on human platelet behaviour and evidence for a selective inhibition of 5‐HT2 receptors. New Trends in Clinical Neuropharmacology 1988;11:13‐4.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21:1539‐58.
Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of randomised controlled trials. BMJ 2001;323:42‐6.
Leponcin‐Lafitte M, Grosdemouge C, Roy‐Billon C, Duterte D, Rapin JR. Effects of naftidrofuryl on cerebral hemodynamics, metabolism and function after a retracted ischaemia. Archives Internationales de Pharmacodynamie et de Therapie 1982;260:218‐29.
Maloteaux JM. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl. Arzneitmittelforschung 1986;36:1194‐8.
Meynaud A, Grand M, Fontaine L. Effect of naftidrofuryl upon energy metabolism of the brain. Arzneitmittelforschung 1973;23:1431.
Meynaud A, Grand A, Belleville M, Fontaine L. Effect of naftidrofuryl on cerebral energy metabolism in mice. 2nd part [Effet du naftidrofuryl sur le metabolisme energetique cerebral chez la souris. Deuxieeme partie]. Therapie 1975;30:777.
Robinson K. A double‐blind clinical trial of naftidrofuryl in cerebral vascular disorders. Medical Digest 1972;17(12):50‐2.
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA. Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. Journal of the American Geriatric Society 1982;30:105‐8.
